Literature DB >> 7386706

Mentally retarded hepatitis-B surface antigen carriers in NYC public school classes: a public health dilemma.

C W Bakal, L F Novick, J S Marr, E S Millner, W D Goldman, O Pitkin.   

Abstract

The placement of retarded children who have been institutionalized and are asymptomatic hepatitis-B surface antigen carriers into public school classes for the retarded has caused controversy and presented the New York City Health Department with an unusual medical-ethical dilemma. In this situation, the cost of interfering with deinstitutionalization, an important social advance, must be balanced against the benefit of controlling the unquantified but real risk of transmitting a potentially serious disease. The Health Department guidelines for managing this problem recommended serological surveillance, promotion of classroom hygiene where possible, and teaching of carriers in classes separate from their susceptible peers. A federal court disallowed the cohorting provisions of these guidelines. Changing policies and practices towards the mentally retarded, such as deinstitutionalization, raise important public health issues which will have to be faced by the involved communities.

Entities:  

Keywords:  Health Care and Public Health; Legal Approach

Mesh:

Substances:

Year:  1980        PMID: 7386706      PMCID: PMC1619463          DOI: 10.2105/ajph.70.7.712

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  23 in total

1.  Hepatitis A and B in the family unit. Nonparenteral transmission by asymptomatic children.

Authors:  T M Vernon; R A Wright; P F Kohler; D A Merrill
Journal:  JAMA       Date:  1976-06-28       Impact factor: 56.272

2.  Role of saliva, urine and feces in the transmission of type B hepatitis.

Authors:  V M Villarejos; K A Visoná; A Gutiérrez; A Rodríguez
Journal:  N Engl J Med       Date:  1974-12-26       Impact factor: 91.245

3.  Hepatitis B transmitted by a human bite.

Authors:  M B MacQuarrie; B Forghani; D A Wolochow
Journal:  JAMA       Date:  1974-11-04       Impact factor: 56.272

4.  The epidemiology of serum hepatitis (SH) infections: a controlled study in two closed institutions.

Authors:  W Szmuness; A M Prince
Journal:  Am J Epidemiol       Date:  1971-12       Impact factor: 4.897

5.  The serum hepatitis virus specific antigen (SH): a preliminary report of epidemiologic studies in an institution for the mentally retarded.

Authors:  W Szmuness; R Pick; A M Prince
Journal:  Am J Epidemiol       Date:  1970-07       Impact factor: 4.897

6.  Issues in behavior modification with mentally retarded persons.

Authors:  A E Kazdin
Journal:  Am J Ment Defic       Date:  1973-09

7.  Familial clustering of hepatitis B infection.

Authors:  W Szmuness; A M Prince; R L Hirsch; B Brotman
Journal:  N Engl J Med       Date:  1973-11-29       Impact factor: 91.245

8.  Letter: Epidemiology of hepatitis B and primary hepatic carcinoma.

Authors:  D Trichopoulos; M Violaki; L Sparros; E Xirouchaki
Journal:  Lancet       Date:  1975-11-22       Impact factor: 79.321

9.  Transmission of hepatitis B by a human bite: an occupational hazard.

Authors:  J D Hamilton; B Larke; A Qizilbash
Journal:  Can Med Assoc J       Date:  1976-09-04       Impact factor: 8.262

10.  Chronic liver disease developing after outbreak of HBsAG-negative hepatitis in haemodialysis unit.

Authors:  R M Galbraith; A L Eddleston; B Portmann; R Williams; P E Gower
Journal:  Lancet       Date:  1975-11-08       Impact factor: 79.321

View more
  2 in total

1.  Hepatitis B infection in a day school for mentally retarded students: transmission from students to staff.

Authors:  R S Remis; M A Rossignol; M A Kane
Journal:  Am J Public Health       Date:  1987-09       Impact factor: 9.308

2.  Hepatitis B virus transmission in a public school: effects of mentally retarded HBsAG carrier students.

Authors:  C A Williams; F T Weber; M McKim; C I Steadham; M A Kane
Journal:  Am J Public Health       Date:  1987-04       Impact factor: 9.308

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.